← Open Payments lookup

DIANA RATEMO: Open Payments

NPI 1750005500 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$683 in 16 payments from 4 companies in 2025. Trend: 2023 $302 · 2024 $149 · 2025 $683

Food & beverage: $674Education: $9
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$230
Otsuka America Pharmaceutical, Inc.4$230
ACADIA Pharmaceuticals Inc5$192
Teva Pharmaceuticals USA, Inc.2$31

Products named: INGREZZA, REXULTI, NUPLAZID, UZEDY.

Industry payments across TX — which companies pay providers there.